These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2408396)

  • 1. Pilus vaccines.
    Tramont EC; Boslego JW
    Vaccine; 1985 Mar; 3(1):3-10. PubMed ID: 2408396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilus peptide vaccine for the prevention of gonorrhea.
    Schoolnik GK; Tai JY; Gotschlich EC
    Prog Allergy; 1983; 33():314-31. PubMed ID: 6187017
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccinating with bacterial pili.
    Marx JL
    Science; 1980 Sep; 209(4461):1103-6. PubMed ID: 6105710
    [No Abstract]   [Full Text] [Related]  

  • 4. Genital antibody response to a parenteral gonococcal pilus vaccine.
    McChesney D; Tramont EC; Boslego JW; Ciak J; Sadoff J; Brinton CC
    Infect Immun; 1982 Jun; 36(3):1006-12. PubMed ID: 6124502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae.
    Sparling PF; Cannon JG; So M
    J Infect Dis; 1986 Feb; 153(2):196-201. PubMed ID: 2418125
    [No Abstract]   [Full Text] [Related]  

  • 6. Human immunization with Pgh 3-2 gonococcal pilus results in cross-reactive antibody to the cyanogen bromide fragment-2 of pilin.
    Johnson SC; Chung RC; Deal CD; Boslego JW; Sadoff JC; Wood SW; Brinton CC; Tramont EC
    J Infect Dis; 1991 Jan; 163(1):128-34. PubMed ID: 1701817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment.
    Tramont EC; Sadoff JC; Boslego JW; Ciak J; McChesney D; Brinton CC; Wood S; Takafuji E
    J Clin Invest; 1981 Oct; 68(4):881-8. PubMed ID: 6116723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against enteric colibacillosis in pigs suckling orally vaccinated dams: evidence for pili as protective antigens.
    Moon HW
    Am J Vet Res; 1981 Feb; 42(2):173-7. PubMed ID: 6114691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine.
    Rothbard JB; Schoolnik GK
    Adv Exp Med Biol; 1985; 185():247-73. PubMed ID: 2416202
    [No Abstract]   [Full Text] [Related]  

  • 10. P-fimbriae vaccines. I. Cross reactive antibodies to heterologous P-fimbriae.
    Kaack MB; Pere A; Korhonen TK; Svenson SB; Roberts JA
    Pediatr Nephrol; 1989 Oct; 3(4):386-90. PubMed ID: 2577146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy trial of a parenteral gonococcal pilus vaccine in men.
    Boslego JW; Tramont EC; Chung RC; McChesney DG; Ciak J; Sadoff JC; Piziak MV; Brown JD; Brinton CC; Wood SW
    Vaccine; 1991 Mar; 9(3):154-62. PubMed ID: 1675029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibody response in mice, rabbits and pigs in response to vaccination with an inactivated oil vaccine containing rotavirus and Escherichia coli strains with K88, K99 and 987P fimbrial antigens].
    Zuffa A; Salajka E; Zajac J; Salajková Z; Zuffa T; Alexa P
    Vet Med (Praha); 1991 Jul; 36(7):423-31. PubMed ID: 1686823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.
    Levine MM; Black RE; Brinton CC; Clements ML; Fusco P; Hughes TP; O'Donnell S; Robins-Browne R; Wood S; Young CR
    Scand J Infect Dis Suppl; 1982; 33():83-95. PubMed ID: 6127806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic peptides: prospects for a pili (fimbriae)-based synthetic vaccine.
    Schmidt MA
    Curr Top Microbiol Immunol; 1990; 151():185-204. PubMed ID: 1973370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gonococcal surface antigens and their significance for serotyping and vaccines].
    Kohl PK; Meyer TF; Petzoldt D
    Hautarzt; 1985 Jun; 36(6):320-5. PubMed ID: 2862130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Continuous and common epitopes present in fimbriae of enterotoxigenic Escherichia coli (ETEC)].
    López-Vidal Y
    Gac Med Mex; 1997; 133(6):511-25. PubMed ID: 9504082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New concepts in vaccines for mucosal non-enteric human bacterial pathogens.
    Westerink MA; Campagnari AA; Nelson MB; Murphy TF; Apicella MA
    Adv Exp Med Biol; 1989; 251():17-31. PubMed ID: 2481958
    [No Abstract]   [Full Text] [Related]  

  • 18. Intragastric inoculation with an E. coli pilus attachment factor (AF/R1) protects against subsequent colonization by an enteropathogen (E. coli strain RDEC-1).
    McQueen CE; Shoham H; Boedeker EC
    Adv Exp Med Biol; 1987; 216B():911-8. PubMed ID: 2892360
    [No Abstract]   [Full Text] [Related]  

  • 19. Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili.
    Stephens DS; Whitney AM; Rothbard J; Schoolnik GK
    J Exp Med; 1985 Jun; 161(6):1539-53. PubMed ID: 2409203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-fimbriae vaccines. II. Cross reactive protection against pyelonephritis.
    Roberts JA; Kaack MB; Baskin G; Korhonen TK; Svenson SB; Winberg J
    Pediatr Nephrol; 1989 Oct; 3(4):391-6. PubMed ID: 2577147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.